help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kageyama, K.
Right arrow Articles by Vale, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kageyama, K.
Right arrow Articles by Vale, W. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Steroids
Endocrinology Vol. 140, No. 12 5651-5658
Copyright © 1999 by The Endocrine Society

ARTICLES

Urocortin Messenger Ribonucleic Acid: Tissue Distribution in the Rat and Regulation in Thymus by Lipopolysaccharide and Glucocorticoids1

Kazunori Kageyama, Margaret J. Bradbury, Lingyun Zhao, Amy L. Blount and Wylie W. Vale2

The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037

Address all correspondence and requests for reprints to: Wylie W. Vale, Ph.D., The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, California 92037. E-mail: vale{at}salk.edu

Urocortin (Ucn), a new mammalian member of the CRF family, is a candidate endogenous ligand for type 2 CRF receptors. In a survey of peripheral tissues from adult male rats, we found that Ucn messenger RNA (mRNA) was abundant in the gastrointestinal tract and immune tissues such as thymus and spleen. We next tested the hypothesis that levels of Ucn mRNA levels in thymus and spleen would be altered after immune activation. As measured by ribonculease protection assay, lipopolysaccharide (LPS) induced a 2-fold time-dependent increase in thymic Ucn mRNA levels within 6 h. By contrast, splenic Ucn mRNA levels decreased after LPS. Because LPS activates the hypothalamus-pituitary-adrenal (HPA) axis, we examined whether the effects of LPS on Ucn mRNA might be mediated through changes in HPA axis hormones. Ucn mRNA in thymus, but not spleen, was significantly increased after ACTH injection; however, LPS did not increase Ucn expression in the thymus of adrenalectomized rats with corticosterone replacement, despite substantial increases in ACTH. Finally, sc injection of corticosterone stimulated Ucn mRNA comparably to that of LPS. Together, these results suggest that Ucn mRNA expression can increase after immune activation in a corticosterone-dependent manner, and that such changes in Ucn mRNA may be an additional consequence of HPA axis activation.




This article has been cited by other articles:


Home page
 GutHome page
E Gonzalez-Rey, A Fernandez-Martin, A Chorny, and M Delgado
Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease
Gut, June 1, 2006; 55(6): 824 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Gonzalez-Rey, A. Chorny, N. Varela, G. Robledo, and M. Delgado
Urocortin and Adrenomedullin Prevent Lethal Endotoxemia by Down-Regulating the Inflammatory Response
Am. J. Pathol., June 1, 2006; 168(6): 1921 - 1930.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
Y. Wu, Y. Xu, H. Zhou, J. Tao, and S. Li
Expression of urocortin in rat lung and its effect on pulmonary vascular permeability.
J. Endocrinol., April 1, 2006; 189(1): 167 - 178.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Xu, J. D. Hennebold, and R. L. Stouffer
Dynamic Expression and Regulation of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Ovary during the Menstrual Cycle
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1544 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. E. la Fleur, E. C. Wick, P. S. Idumalla, E. F. Grady, and A. Bhargava
From the Cover: Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum
PNAS, May 24, 2005; 102(21): 7647 - 7652.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. M. Gardiner, J. E. March, P. A. Kemp, A. P. Davenport, K. E. Wiley, and T. Bennett
Regional Hemodynamic Actions of Selective Corticotropin-Releasing Factor Type 2 Receptor Ligands in Conscious Rats
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Lu, L. Dow, S. Gumusgoz, M. J. Brierley, J. M. Warne, C. R. McCrohan, R. J. Balment, and D. Riccardi
Coexpression of Corticotropin-Releasing Hormone and Urotensin I Precursor Genes in the Caudal Neurosecretory System of the Euryhaline Flounder (Platichthys flesus): A Possible Shared Role in Peripheral Regulation
Endocrinology, December 1, 2004; 145(12): 5786 - 5797.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Chen, A. Blount, J. Vaughan, B. Brar, and W. Vale
Urocortin II Gene Is Highly Expressed in Mouse Skin and Skeletal Muscle Tissues: Localization, Basal Expression in Corticotropin-Releasing Factor Receptor (CRFR) 1- and CRFR2-Null Mice, and Regulation by Glucocorticoids
Endocrinology, May 1, 2004; 145(5): 2445 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Chen, J. Vaughan, and W. W. Vale
Glucocorticoids Regulate the Expression of the Mouse Urocortin II Gene: A Putative Connection between the Corticotropin-Releasing Factor Receptor Pathways
Mol. Endocrinol., August 1, 2003; 17(8): 1622 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kageyama and T. Suda
Urocortin-Related Peptides Increase Interleukin-6 Output via Cyclic Adenosine 5'-Monophosphate-Dependent Pathways in A7r5 Aortic Smooth Muscle Cells
Endocrinology, June 1, 2003; 144(6): 2234 - 2241.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kageyama, C. Li, and W. W. Vale
Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids
Endocrinology, April 1, 2003; 144(4): 1524 - 1532.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. L. Hauger, D. E. Grigoriadis, M. F. Dallman, P. M. Plotsky, W. W. Vale, and F. M. Dautzenberg
International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands
Pharmacol. Rev., March 1, 2003; 55(1): 21 - 26.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Chatzaki, I. Charalampopoulos, C. Leontidis, I. A. Mouzas, M. Tzardi, C. Tsatsanis, A. N. Margioris, and A. Gravanis
Urocortin in Human Gastric Mucosa: Relationship to Inflammatory Activity
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 478 - 483.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. M. Scarabelli, E. Pasini, A. Stephanou, L. Comini, S. Curello, R. Raddino, R. Ferrari, R. Knight, and D. S. Latchman
urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 155 - 161.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Kimura, K. Takahashi, K. Totsune, Y. Muramatsu, C. Kaneko, A. D. Darnel, T. Suzuki, M. Ebina, T. Nukiwa, and H. Sasano
Expression of Urocortin and Corticotropin-Releasing Factor Receptor Subtypes in the Human Heart
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 340 - 346.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Kohno, Y. Kawahito, Y. Tsubouchi, A. Hashiramoto, R. Yamada, K.-i. Inoue, Y. Kusaka, T. Kubo, I. J. Elenkov, G. P. Chrousos, et al.
Urocortin Expression in Synovium of Patients with Rheumatoid Arthritis and Osteoarthritis: Relation to Inflammatory Activity
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4344 - 4352.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. C. Coste, K. A. Heldwein, S. L. Stevens, E. Tobar-Dupres, and M. P. Stenzel-Poore
IL-1{alpha} and TNF{alpha} Down-Regulate CRH Receptor-2 mRNA Expression in the Mouse Heart
Endocrinology, August 1, 2001; 142(8): 3537 - 3545.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. SLOMINSKI, J. WORTSMAN, A. PISARCHIK, B. ZBYTEK, E. A. LINTON, J. E. MAZURKIEWICZ, and E. T. WEI
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
FASEB J, August 1, 2001; 15(10): 1678 - 1693.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. E. Murray, H. R. Lallman, A. D. Heard, M. B. Rittenberg, and M. P. Stenzel-Poore
A Genetic Model of Stress Displays Decreased Lymphocytes and Impaired Antibody Responses Without Altered Susceptibility to Streptococcus pneumoniae
J. Immunol., July 15, 2001; 167(2): 691 - 698.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kageyama, G. E. Gaudriault, M. J. Bradbury, and W. W. Vale
Regulation of Corticotropin-Releasing Factor Receptor Type 2{beta} Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines
Endocrinology, July 1, 2000; 141(7): 2285 - 2293.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society